Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gingko biloba in healthy middle-aged adults
NCT02181972Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2002
- Primary completion
- Nov 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ginkgo biloba extract in age-related cognitive decline, sponsored by Boehringer Ingelheim. Started May 2002; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
age-related cognitive decline
Beyond the preview
Go deeper on NCT02181972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181972.